During the past decade, Parkinson Klinik Wolfach conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Parkinson Klinik Wolfach" are "Dementia With Parkinson's Disease" (1 trials), "Depression" (1 trials), "Migraine Disorders" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Parkinson Klinik Wolfach" in a lesser frequency.

Most popular intervention types in "Parkinson Klinik Wolfach" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ARICEPT" (1 trials), "Pramipexole" (1 trials) and "botulinum toxin Type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkinson Klinik Wolfach" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Parkinson Klinik Wolfach". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Parkinson Klinik Wolfach, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Parkinson Klinik Wolfach, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".